Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Petry

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The Journal of General Virology|October 1, 1996
T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaquesU Dittmer, H Petry, C Stahl-Hennig, et al.
Pigment Cell Research|December 1, 1994
Increasing melanoma incidence: putatively explainable by retrotransposons. Experimental contributions of the xiphophorine Gordon-Kosswig melanoma systemA Anders, H Petry, C Fleming, et al.
Gene Therapy|April 8, 2011
AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1iA Koornneef, R van Logtenstein, E Timmermans, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeysT Igarashi, R Shibata, F Hasebe, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivoC Stahl-Hennig, C Coulibaly, H Petry, et al.
Immunology Letters|June 1, 1996
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletionC Stahl-Hennig, U Dittmer, T Nisslein, et al.
Journal of Virology|March 1, 1995
Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfectionH Petry, U Dittmer, C Stahl-Hennig, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Gene Therapy|March 17, 2017
MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brainL Samaranch, B Blits, W San Sebastian, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The Journal of General Virology|October 1, 1996
T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaquesU Dittmer, H Petry, C Stahl-Hennig, et al.
Pigment Cell Research|December 1, 1994
Increasing melanoma incidence: putatively explainable by retrotransposons. Experimental contributions of the xiphophorine Gordon-Kosswig melanoma systemA Anders, H Petry, C Fleming, et al.
Gene Therapy|April 8, 2011
AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1iA Koornneef, R van Logtenstein, E Timmermans, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeysT Igarashi, R Shibata, F Hasebe, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivoC Stahl-Hennig, C Coulibaly, H Petry, et al.
Immunology Letters|June 1, 1996
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletionC Stahl-Hennig, U Dittmer, T Nisslein, et al.
Journal of Virology|March 1, 1995
Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfectionH Petry, U Dittmer, C Stahl-Hennig, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Gene Therapy|March 17, 2017
MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brainL Samaranch, B Blits, W San Sebastian, et al.
Pageof 8